Pharma Engineering Insights

PLC vs DCS in Pharmaceutical Manufacturing: How to Select the Right Control Architecture

Compare PLC and DCS by process type, batch control, integration, redundancy, maintainability and lifecycle cost without a universal winner.

G GuideGxP 9 min read
✓ Official sources and references ✓ Practical approach ✓ For pharmaceutical professionals
GUIDEGXP · PRACTICAL GMP INSIGHTS
Comparison of industrial control platforms beside pharmaceutical process equipment

A project team comparing a PLC quotation with a DCS quotation may be comparing two different scopes. One price may include only controllers and basic engineering; the other may include coordinated batch control, operator stations, libraries, history and lifecycle services. Selecting the cheaper controller before reconciling those boundaries can move cost and risk into integration, qualification and long-term support.

The useful question is which control architecture can execute the intended process, preserve the required evidence and remain supportable through its lifecycle. Neither PLC nor DCS is universally superior for pharmaceutical manufacturing. Modern offerings overlap significantly, and the actual configuration matters more than a product category.

Define the process behaviour that must be controlled

Start with process narratives and equipment boundaries. Discrete operations often emphasize machine states, interlocks, motion and rapid repeatable sequences. Continuous operations emphasize coordinated regulatory control and sustained operation. Batch processes combine equipment capabilities, procedural steps, recipes, holds and transitions. A pharmaceutical facility may contain all three, including vendor skids with their own controls.

Identify which decisions must execute locally and which require coordination across units. Document the consequences of interrupted control, unavailable supervision and missing records separately. A packaging machine, a water generation plant and a multiproduct reactor suite do not acquire identical requirements simply because all operate under GMP.

[QRM] Assess product quality, patient safety, data integrity and operational consequences at the function level. A platform selection cannot be justified by counting critical instruments alone. The relationships between functions, shared dependencies and recovery behaviour can dominate the architecture decision.

Compare complete solutions rather than historical stereotypes

A programmable logic controller is a controller technology around which a broader automation solution can be built. A distributed control system usually offers an integrated environment for distributed process control and supervision. However, PLC-based solutions can include sophisticated batch, redundancy and information functions, while a DCS still requires deliberate application engineering and external interfaces.

Avoid claims such as “PLCs cannot support batch manufacturing” or “a DCS is automatically GMP compliant.” Ask what the proposed release, modules and configuration actually do. The same product family can be deployed with very different availability, security and record capabilities. Marketing descriptions rarely establish those implementation details.

Normalize each proposal into the same scope: controllers, I/O, engineering tools, operator interfaces, batch execution, historian, identity, audit functionality, infrastructure, interfaces, licences, testing, documentation, training and support. Identify excluded functions and the party expected to supply them. A comparison is incomplete while essential scope remains marked “by others” without an accountable owner.

Use decision criteria with evidence behind them

CriterionQuestions for either architectureUseful evidence
Process fitCan the solution express the actual states, loops and sequences clearly?Representative process demonstration and reviewed functional design
Batch coordinationWho owns recipes, resource arbitration and restart behaviour?Executed batch scenarios including holds and abnormal transitions
AvailabilityWhich failures are tolerated and which remain common dependencies?Architecture analysis and controlled failure demonstrations
MaintainabilityCan site staff diagnose, restore and modify the application?Maintenance exercises, source access and supported engineering environment
Records and integrationHow are actions, process data and manufacturing transactions preserved?End-to-end record reconstruction and interface reconciliation
Lifecycle economicsWhat must be renewed, upgraded or supported over the selected horizon?Itemized lifecycle assumptions and contractual responsibilities

Set weights only after stakeholders agree on consequences and constraints. Treat an essential requirement as a gate, not as a low score that can be offset by attractive graphics or a lower licence price. Record why the criteria differ between projects.

Examine recipe execution and batch state

A recipe is more than a list of setpoints. Determine how procedural structure, parameter limits, equipment allocation and version approval are represented. Separate the approved master definition from the instance used for a specific batch. Retain the relationship between the approved version, any authorized adjustments and what actually executed.

Review hold, stop, abort and restart behaviour with process specialists. The same word can have different meanings in different packages. Define what happens to valves, agitation, heating and material routing in each state, and which conditions permit resumption. A restart must not silently repeat a material addition or omit an incomplete verification.

[STANDARD] ISA-88 offers batch-control concepts that can support this design. It does not make every implementation of a named batch module suitable for a particular process. Request evidence that the proposed application represents the site's recipes and abnormal states faithfully, including interfaces to packaged equipment and operator-dependent actions.

Understand redundancy at the service level

Ask what is redundant: CPU, power supply, I/O, network, server, storage, operator station or service. Then ask what remains shared. Two controllers using the same unsupported communication module may not protect the failure that matters. Two supervisory servers can remain dependent on one storage service or one identity configuration.

Specify the expected process and record behaviour during failover. Evaluate interrupted commands, transient indications, alarm generation, buffered data and recovery of batch context. “Seamless” requires an acceptance definition: continuity of which function, under which failure, with what observable effects? Derive those expectations from the process rather than adopting an undefined vendor claim.

Not every system needs duplicated hardware. For a bounded machine, controlled shutdown and rapid recovery may be a justified strategy; another process may require continuity through specified failures. Document the risk assessment, operational response and residual limitations. Redundancy should address assessed scenarios and be tested without creating unacceptable hazards.

Evaluate engineering tools and change control

Engineering efficiency affects lifecycle risk. Examine configuration comparison, version management, library reuse, access segregation and the relationship between online and archived code. Determine how an authorized engineer confirms the running version and identifies unauthorized or unexplained differences. A backup that cannot be associated with the deployed application is a weak recovery basis.

Consider the impact of changing one equipment object. Does the change affect a single controller, many units, shared graphics or a common database? Can affected installations be identified? Can the change be tested in a representative environment before deployment? Integrated platforms can simplify consistency while increasing the consequences of shared configuration changes.

[GEP] Establish coding and configuration conventions with explicit ownership. These should cover naming, reusable functions, error handling, diagnostics and prohibited shortcuts. Evaluate how suppliers demonstrate compliance with those conventions. Code volume, document count and a familiar programming language are poor substitutes for understandable, controlled application behaviour.

Make operator experience part of the selection

An architecture determines how operators navigate units, understand authority and recover from abnormal conditions. Demonstrate routine tasks and difficult ones: locating a failed permissive, identifying a stale value, comparing actual and intended recipe parameters, and transferring responsibility between local and central operation.

Consistency matters across packaged equipment. A common SCADA screen does not guarantee common state meanings underneath it. Operators must understand which commands are available, which controller owns the equipment and whether an action was accepted. Avoid interfaces that display a button press as a completed process action before the controller confirms the result.

Use representative operators in evaluations and record observed task failures. The SCADA and HMI design article covers these principles in detail. For selection, translate observations into requirements and acceptance scenarios so that usability findings influence procurement rather than remaining informal preferences.

Account for GMP evidence without confusing product features with compliance

[REGULATORY REQUIREMENT] Apply the relevant computerized-system and documentation requirements to the intended use. EU GMP Annex 11 and Chapter 4 remained the 2011 operative texts at this article's review date; Annex 15 provides the qualification and validation framework. Part 11 applicability in the United States depends on the records and signatures concerned. Neither framework mandates PLC or DCS as a universal platform choice.

Determine how the proposed solution preserves attributable actions, relevant changes, access control, time information and records needed for review. Some capabilities may reside outside the controller. Confirm the complete path from process event to retained record and identify any manual steps or uncontrolled exports.

[GUIDANCE] FDA's February 2026 Computer Software Assurance guidance concerns medical-device production and quality management system software. Its risk-based principles must not be described as a blanket replacement for pharmaceutical GMP validation. Select assurance activities according to applicable requirements, intended use and assessed risk, with evidence that critical functions work as specified.

Calculate cost using a transparent lifecycle model

Compare acquisition, implementation and recurring costs over an agreed planning horizon. Include licences, infrastructure, engineering, integration, qualification support, training, service, spares, cybersecurity maintenance and planned upgrades. State assumptions about expansion and support rather than presenting one unexplained total.

Assess the cost of dependency. A lower initial price may rely on scarce specialists, proprietary libraries or a remote service model unsuitable for the site's operating hours. A more integrated solution may reduce interface work but increase migration cost. Neither outcome can be inferred from the platform label alone.

Model credible scenarios: another production unit, a supported software upgrade, replacement of an obsolete server and recovery after a significant failure. Distinguish committed vendor prices from site estimates and uncertain downtime assumptions. Avoid manufactured precision. A range with visible assumptions can support a better decision than a single unsupported return-on-investment figure.

Worked example: selecting control for a multiproduct suite

An illustrative site is adding three process units and two packaged skids. One proposal uses PLCs with a shared supervisory and batch layer; another uses a DCS with integrated batch functions. The team first aligns both scopes, including historian connectivity, recipe approval, identity integration and long-term support.

The decisive demonstration is an interrupted transfer between units followed by recovery. Both suppliers must show equipment ownership, prevention of repeated material addition, retained batch context and clear operator instructions. The team also asks site maintenance staff to diagnose a simulated communication fault using the proposed tools.

One implementation demonstrates stronger integrated resource coordination; the other offers better continuity with installed equipment and local skills. The final decision weighs the actual process and lifecycle evidence against agreed constraints. It is not a declaration that one technology is always preferable. The rejected option's limitations and the selected option's residual risks are documented for subsequent design review.

Use a representative demonstration before commitment

A selection demonstration should challenge a bounded but representative process scenario. Provide the same narrative, starting conditions and expected outcomes to each supplier. Include normal execution, an invalid command, loss of an input and a recovery sequence. Require the supplier to explain configuration and dependencies rather than showing only a prepared operator screen.

Observe how much custom work is needed and who could maintain it later. Ask which functions are standard product capabilities, configured library behaviour or project-specific code. Retain the demonstrated configuration identity and distinguish demonstrated results from statements about future development. A promised feature needs a contractual delivery and acceptance condition.

After the demonstration, review open issues with process, operations, maintenance, automation and quality representatives. Some findings may be acceptable with procedural controls; others may reveal a fundamental mismatch. Document the basis for that distinction. Do not convert every imperfection into a platform rejection, but do not allow a polished demonstration to conceal missing evidence for a critical requirement.

Build a defensible selection record

Before approval, reconcile the technical evaluation with the purchase scope. Carry unresolved assumptions into specific deliverables, responsible parties and acceptance conditions. Confirm the versions demonstrated are the versions offered, and identify how substitutions will be assessed. Supplier demonstrations inform selection but do not replace verification of the delivered system.

  • Process narratives and abnormal states are agreed.
  • Both options include equivalent functional and service scope.
  • Essential requirements have objective acceptance evidence.
  • Common dependencies and recovery limitations are recorded.
  • Site staff can support the proposed engineering environment.
  • Record ownership and interface responsibilities are assigned.
  • Lifecycle costs and contractual exclusions are visible.

Read the broader GMP automation architecture method before freezing boundaries. Connect control choices to the relevant equipment context, including Water & WFI Systems and Aseptic Fill-Finish & Barrier Systems. The Automation & Digital Systems hub brings the related engineering decisions together.

Primary references and status

Reviewed 23 September 2026. European Commission: EudraLex Volume 4; 21 CFR Part 11; ISA standards catalogue, including ISA-88; FDA Computer Software Assurance, final February 2026. Comparison criteria and examples are GuideGxP engineering recommendations, not proprietary standard tables or universal regulatory prescriptions.

THE PRAGMATIC GMP · EVERY MONDAY

The GMP topics that matter, in 7 minutes.

One GMP topic, one real-world example and one practical action, based on official sources and inspection trends.
Discover The Pragmatic GMP